(RCO) Remy Cointreau - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000130395
Stock: Cognac, Liqueur, Whisky, Rum, Champagne
Total Rating 40
Risk 97
Buy Signal -0.23
Dividends
| Dividend Yield | 1.70% |
| Yield on Cost 5y | 0.71% |
| Yield CAGR 5y | -14.26% |
| Payout Consistency | 83.3% |
| Payout Ratio | 85.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 41.7% |
| Relative Tail Risk | -13.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.15 |
| Alpha | -16.63 |
| Character TTM | |
|---|---|
| Beta | 0.154 |
| Beta Downside | 0.250 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.80% |
| CAGR/Max DD | -0.44 |
Description: RCO Remy Cointreau January 11, 2026
Rémy Cointreau SA (ticker RCO) is a French-based, family-controlled group that produces, markets, and distributes premium liqueurs and spirits through three operating segments: Rémy Martin, Liqueurs & Spirits, and Partner Brands.
The portfolio spans iconic cognacs (Rémy Martin, Louis XIII), liqueurs (Cointreau, Metaxa), single-malt whiskies (Bruichladdich, Octomore, Westland), gin (The Botanist), rum (Mount Gay), and a selection of wines and champagnes, giving the group exposure across multiple high-margin spirit categories.
Its distribution network covers Europe, the Middle East & Africa, the Americas, and the Asia-Pacific region, with China and the United States representing the two largest growth markets for premium spirits.
In FY 2023 the company reported €2.2 billion in revenue, up 12 % on a comparable-company basis, and an adjusted operating margin of roughly 20 %; however, earnings remain sensitive to euro-dollar exchange fluctuations and to the ongoing premium-ization trend that can amplify demand volatility in emerging markets.
For a deeper, data-driven view of how these dynamics translate into valuation metrics, you may find the ValueRay analysis worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 256.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 4.13 > 1.0 |
| NWC/Revenue: 77.23% < 20% (prev 60.21%; Δ 17.02% < -1%) |
| CFO/TA 0.06 > 3% & CFO 221.3m > Net Income 256.2m |
| Net Debt (686.8m) to EBITDA (518.6m): 1.32 < 3 |
| Current Ratio: 2.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.3m) vs 12m ago 2.63% < -2% |
| Gross Margin: 67.48% > 18% (prev 0.69%; Δ 6679 % > 0.5%) |
| Asset Turnover: 58.01% > 50% (prev 70.93%; Δ -12.92% > 0%) |
| Interest Coverage Ratio: 8.57 > 6 (EBITDA TTM 518.6m / Interest Expense TTM 50.1m) |
Altman Z'' 5.43
| A: 0.45 (Total Current Assets 2.45b - Total Current Liabilities 876.4m) / Total Assets 3.46b |
| B: 0.28 (Retained Earnings 957.9m / Total Assets 3.46b) |
| C: 0.12 (EBIT TTM 429.5m / Avg Total Assets 3.50b) |
| D: 0.69 (Book Value of Equity 1.06b / Total Liabilities 1.54b) |
| Altman-Z'' Score: 5.43 = AAA |
Beneish M -3.16
| DSRI: 0.98 (Receivables 182.0m/230.4m, Revenue 2.03b/2.51b) |
| GMI: 1.02 (GM 67.48% / 68.69%) |
| AQI: 0.99 (AQ_t 0.16 / AQ_t-1 0.16) |
| SGI: 0.81 (Revenue 2.03b / 2.51b) |
| TATA: 0.01 (NI 256.2m - CFO 221.3m) / TA 3.46b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of RCO shares?
As of February 09, 2026, the stock is trading at EUR 43.54 with a total of 74,228 shares traded.
Over the past week, the price has changed by +9.45%, over one month by +8.31%, over three months by +1.59% and over the past year by -11.04%.
Over the past week, the price has changed by +9.45%, over one month by +8.31%, over three months by +1.59% and over the past year by -11.04%.
Is RCO a buy, sell or hold?
Remy Cointreau has no consensus analysts rating.
What are the forecasts/targets for the RCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 43.8 | 0.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32.9 | -24.4% |
RCO Fundamental Data Overview February 09, 2026
Market Cap USD = 2.48b (2.10b EUR * 1.1801 EUR.USD)
P/E Trailing = 22.7727
P/E Forward = 15.4083
P/S = 2.2307
P/B = 1.0748
P/EG = 1.6886
Revenue TTM = 2.03b EUR
EBIT TTM = 429.5m EUR
EBITDA TTM = 518.6m EUR
Long Term Debt = 565.8m EUR (from longTermDebt, last quarter)
Short Term Debt = 170.0m EUR (from shortTermDebt, last quarter)
Debt = 757.3m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 686.8m EUR (from netDebt column, last quarter)
Enterprise Value = 2.78b EUR (2.10b + Debt 757.3m - CCE 70.5m)
Interest Coverage Ratio = 8.57 (Ebit TTM 429.5m / Interest Expense TTM 50.1m)
EV/FCF = 24.13x (Enterprise Value 2.78b / FCF TTM 115.4m)
FCF Yield = 4.14% (FCF TTM 115.4m / Enterprise Value 2.78b)
FCF Margin = 5.68% (FCF TTM 115.4m / Revenue TTM 2.03b)
Net Margin = 12.61% (Net Income TTM 256.2m / Revenue TTM 2.03b)
Gross Margin = 67.48% ((Revenue TTM 2.03b - Cost of Revenue TTM 660.7m) / Revenue TTM)
Gross Margin QoQ = 63.28% (prev 62.99%)
Tobins Q-Ratio = 0.80 (Enterprise Value 2.78b / Total Assets 3.46b)
Interest Expense / Debt = 2.13% (Interest Expense 16.1m / Debt 757.3m)
Taxrate = 28.00% (24.5m / 87.5m)
NOPAT = 309.2m (EBIT 429.5m * (1 - 28.00%))
Current Ratio = 2.79 (Total Current Assets 2.45b / Total Current Liabilities 876.4m)
Debt / Equity = 0.39 (Debt 757.3m / totalStockholderEquity, last quarter 1.92b)
Debt / EBITDA = 1.32 (Net Debt 686.8m / EBITDA 518.6m)
Debt / FCF = 5.95 (Net Debt 686.8m / FCF TTM 115.4m)
Total Stockholder Equity = 1.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.32% (Net Income 256.2m / Total Assets 3.46b)
RoE = 13.49% (Net Income TTM 256.2m / Total Stockholder Equity 1.90b)
RoCE = 17.42% (EBIT 429.5m / Capital Employed (Equity 1.90b + L.T.Debt 565.8m))
RoIC = 11.87% (NOPAT 309.2m / Invested Capital 2.61b)
WACC = 5.17% (E(2.10b)/V(2.86b) * Re(6.48%) + D(757.3m)/V(2.86b) * Rd(2.13%) * (1-Tc(0.28)))
Discount Rate = 6.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.31%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈115.4m ; Y1≈75.8m ; Y5≈34.6m
Fair Price DCF = 7.92 (EV 1.10b - Net Debt 686.8m = Equity 414.5m / Shares 52.3m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -18.10 | EPS CAGR: -33.48% | SUE: 0.0 | # QB: 0
Revenue Correlation: -17.93 | Revenue CAGR: -5.94% | SUE: 0.68 | # QB: 0
EPS next Year (2027-03-31): EPS=1.81 | Chg30d=-0.088 | Revisions Net=-2 | Growth EPS=+12.2% | Growth Revenue=+4.2%
P/E Trailing = 22.7727
P/E Forward = 15.4083
P/S = 2.2307
P/B = 1.0748
P/EG = 1.6886
Revenue TTM = 2.03b EUR
EBIT TTM = 429.5m EUR
EBITDA TTM = 518.6m EUR
Long Term Debt = 565.8m EUR (from longTermDebt, last quarter)
Short Term Debt = 170.0m EUR (from shortTermDebt, last quarter)
Debt = 757.3m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 686.8m EUR (from netDebt column, last quarter)
Enterprise Value = 2.78b EUR (2.10b + Debt 757.3m - CCE 70.5m)
Interest Coverage Ratio = 8.57 (Ebit TTM 429.5m / Interest Expense TTM 50.1m)
EV/FCF = 24.13x (Enterprise Value 2.78b / FCF TTM 115.4m)
FCF Yield = 4.14% (FCF TTM 115.4m / Enterprise Value 2.78b)
FCF Margin = 5.68% (FCF TTM 115.4m / Revenue TTM 2.03b)
Net Margin = 12.61% (Net Income TTM 256.2m / Revenue TTM 2.03b)
Gross Margin = 67.48% ((Revenue TTM 2.03b - Cost of Revenue TTM 660.7m) / Revenue TTM)
Gross Margin QoQ = 63.28% (prev 62.99%)
Tobins Q-Ratio = 0.80 (Enterprise Value 2.78b / Total Assets 3.46b)
Interest Expense / Debt = 2.13% (Interest Expense 16.1m / Debt 757.3m)
Taxrate = 28.00% (24.5m / 87.5m)
NOPAT = 309.2m (EBIT 429.5m * (1 - 28.00%))
Current Ratio = 2.79 (Total Current Assets 2.45b / Total Current Liabilities 876.4m)
Debt / Equity = 0.39 (Debt 757.3m / totalStockholderEquity, last quarter 1.92b)
Debt / EBITDA = 1.32 (Net Debt 686.8m / EBITDA 518.6m)
Debt / FCF = 5.95 (Net Debt 686.8m / FCF TTM 115.4m)
Total Stockholder Equity = 1.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.32% (Net Income 256.2m / Total Assets 3.46b)
RoE = 13.49% (Net Income TTM 256.2m / Total Stockholder Equity 1.90b)
RoCE = 17.42% (EBIT 429.5m / Capital Employed (Equity 1.90b + L.T.Debt 565.8m))
RoIC = 11.87% (NOPAT 309.2m / Invested Capital 2.61b)
WACC = 5.17% (E(2.10b)/V(2.86b) * Re(6.48%) + D(757.3m)/V(2.86b) * Rd(2.13%) * (1-Tc(0.28)))
Discount Rate = 6.48% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.31%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈115.4m ; Y1≈75.8m ; Y5≈34.6m
Fair Price DCF = 7.92 (EV 1.10b - Net Debt 686.8m = Equity 414.5m / Shares 52.3m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -18.10 | EPS CAGR: -33.48% | SUE: 0.0 | # QB: 0
Revenue Correlation: -17.93 | Revenue CAGR: -5.94% | SUE: 0.68 | # QB: 0
EPS next Year (2027-03-31): EPS=1.81 | Chg30d=-0.088 | Revisions Net=-2 | Growth EPS=+12.2% | Growth Revenue=+4.2%